{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:51:22Z","timestamp":1790401882296,"version":"4.1.0"},"reference-count":29,"publisher":"Impact Journals, LLC","issue":"27","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,7,4]]},"DOI":"10.18632\/oncotarget.17961","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T12:20:13Z","timestamp":1495110013000},"page":"44639-44653","source":"Crossref","is-referenced-by-count":29,"title":["Riluzole exerts distinct antitumor effects from a metabotropic glutamate receptor 1-specific inhibitor on breast cancer cells"],"prefix":"10.18632","volume":"8","author":[{"given":"Sonia C.","family":"Dolfi","sequence":"first","affiliation":[{"name":"Department of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Medina","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Kareddula","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavna","family":"Paratala","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Rose","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatinder","family":"Dhami","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzie","family":"Chen","sequence":"additional","affiliation":[{"name":"Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shridar","family":"Ganesan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Mackay","sequence":"additional","affiliation":[{"name":"CRUK Beatson Institute, Garscube Estate, Bearsden, Glasgow G61 1BD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"Vazquez","sequence":"additional","affiliation":[{"name":"CRUK Beatson Institute, Garscube Estate, Bearsden, Glasgow G61 1BD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M.","family":"Hirshfield","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,5,18]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"e69851","DOI":"10.1371\/journal.pone.0069851","article-title":"Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes","volume":"8","author":"Toppmeyer","year":"2013","journal-title":"PLoS One"},{"key":"2","first-page":"331","article-title":"Glutamatergic signaling in cellular transformation","volume":"2","author":"Chen","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7150\/ijbs.6475","article-title":"Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications","volume":"9","author":"Koochekpour","year":"2013","journal-title":"Int J Biol Sci"},{"key":"4","first-page":"565","article-title":"Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer","volume":"13","author":"Gorski","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"5","doi-asserted-by":"crossref","first-page":"e88830","DOI":"10.1371\/journal.pone.0088830","article-title":"Metabotropic glutamate receptor-1 as a novel target for the antiangiogenic treatment of breast cancer","volume":"9","author":"Gorski","year":"2014","journal-title":"PLoS One"},{"key":"6","doi-asserted-by":"crossref","first-page":"e81126","DOI":"10.1371\/journal.pone.0081126","article-title":"Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer","volume":"9","author":"Gorski","year":"2014","journal-title":"PLoS One"},{"key":"7","first-page":"781","article-title":"Cancer cell lines release glutamate into the extracellular environment","volume":"2","author":"Singh","year":"2009","journal-title":"Clin Exp Metastasis"},{"key":"8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/aja.2012.145","article-title":"Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer","volume":"1","author":"Koochekpour","year":"2013","journal-title":"Asian J Androl"},{"key":"9","first-page":"435","article-title":"Expression of glutamate receptor subunits in human cancers","volume":"13","author":"Ikonomidou","year":"2009","journal-title":"Histochem Cell Biol"},{"key":"10","first-page":"108","article-title":"Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia","volume":"3","author":"Yudt","year":"2003","journal-title":"Nat Genet"},{"key":"11","first-page":"209","article-title":"Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo","volume":"14","author":"Glowinski","year":"1992","journal-title":"Neurosci Lett"},{"key":"12","first-page":"1227","article-title":"Effects of riluzole on electrically evoked neurotransmitter release","volume":"13","author":"Feuerstein","year":"2000","journal-title":"Br J Pharmacol"},{"key":"13","first-page":"7080","article-title":"Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies","volume":"1","author":"Chen","year":"2011","journal-title":"Clin Cancer Res"},{"key":"14","first-page":"2298","article-title":"Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma","volume":"6","author":"Chen","year":"2007","journal-title":"Cancer Res"},{"key":"15","first-page":"1279","article-title":"Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1\/2 via PKCepsilon","volume":"1","author":"Chen","year":"2006","journal-title":"Cell Signal"},{"key":"16","first-page":"103","article-title":"AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1)","volume":"2","author":"Chen","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"17","first-page":"3896","article-title":"A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma","volume":"1","author":"Goydos","year":"2009","journal-title":"Clin Cancer Res"},{"key":"18","first-page":"1807","article-title":"Riluzole enhances ionizing radiation-induced cytotoxicity in human melanoma cells that ectopically express metabotropic glutamate receptor 1 in vitro and in vivo","volume":"1","author":"Haffty","year":"2011","journal-title":"Clin Cancer Res"},{"key":"19","first-page":"105","article-title":"Riluzole is a radio-sensitizing agent in an in vivo model of brain metastasis derived from GRM1 expressing human melanoma cells","volume":"2","author":"Chen","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"20","first-page":"5888","article-title":"Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells","volume":"1","author":"Sartor","year":"2012","journal-title":"Clin Cancer Res"},{"key":"21","first-page":"57","article-title":"Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells","volume":"15","author":"Chen","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"22","first-page":"1049","article-title":"Two molecularly distinct G(2)\/M checkpoints are induced by ionizing irradiation","volume":"2","author":"Kastan","year":"2002","journal-title":"Mol Cell Biol"},{"key":"23","first-page":"271","article-title":"Understanding the limitations of radiation-induced cell cycle checkpoints","volume":"4","author":"L\u00f6brich","year":"2011","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"24","first-page":"263","article-title":"Disruption of GRM1-mediated signaling using riluzole results in DNA damage in melanoma cells","volume":"2","author":"Chen","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"25","first-page":"217","article-title":"Riluzole mediates anti-tumor properties in breast cancer cells independent of metabotropic glutamate receptor-1","volume":"15","author":"Gorski","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"26","first-page":"6522","article-title":"Nucleoside analogs: molecular mechanisms signaling cell death","volume":"2","author":"Plunkett","year":"2008","journal-title":"Oncogene"},{"key":"27","article-title":"A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor (GRM1) signaling, in advanced melanoma","volume":"2","author":"Goydos","year":"2011","journal-title":"J Clin Oncol"},{"key":"28","first-page":"15545","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"10","author":"Mesirov","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"29","first-page":"3212","article-title":"Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone orbitrap mass spectrometer","volume":"8","author":"Rabinowitz","year":"2010","journal-title":"Anal Chem"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17961","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T14:26:46Z","timestamp":1597674406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,18]]},"references-count":29,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2017,7,4]]}},"alternative-id":["17961","28591718"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.17961","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,18]]}}}